Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 1(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04360044Phase 2Completed

Efficacy of Inhaled Cannabis for Acute Migraine Treatment

Role: collaborator

NCT04260087Terminated

New Daily Persistent Headache Biomarkers Study

Role: collaborator

NCT02358681Phase 3Completed

Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children

Role: collaborator

NCT02101892Not ApplicableCompleted

Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation

Role: collaborator

NCT01389193Phase 1Completed

Ibudilast in the Treatment of Patients With Chronic Migraine.

Role: collaborator

NCT01314651Not ApplicableCompleted

Efficacy of Behavioral Insomnia Treatment for Chronic Migraine

Role: collaborator

NCT01182051Not ApplicableCompleted

A Study of Family-based Cognitive-behavioral Therapy for Chronic Pediatric Headache and Anxiety

Role: collaborator

All 7 trials loaded